Related Experiment Video
Updated: Feb 8, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Notch signaling pathway mediates Doxorubicin-driven apoptosis in cancers
Zixin Huang1, Shuibin Lin2, Chongde Long1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Background:
Doxorubicin is a widely used chemotherapy drug for the treatment of a variety of cancers, however it also has serious side effects such as anaphylaxis and heart damage. Therefore, it's very important to understand the downstream molecular pathways that are essential for Doxorubicin function in cancer treatment.
Methods:
HeLa S3 cells were treated with different concentrations of Doxorubicin for 24 hours. Then, the mRNA levels of Notch pathway components in the Doxorubicin treated cells were determined by Real-Time qRT-PCR. Lentiviral transfection was used to up-regulate and down-regulate HES1 expression. Cell proliferation and apoptosis were measured with MTT assay and flow cytometry. Finally, immunofluorescence was used to detect protein subcellular location.
Result:
Doxorubicin treatment strongly increases the expression of multiple Notch pathway components in cancer cells. The Notch target HES1 is activated by Doxorubicin and is required for the Doxorubicin driven apoptosis. In addition, over-expression of HES1 can further enhances Doxorubicin's role in promoting apoptosis. Mechanistically, HES1 activates PARP1 and regulates the subcellular location of AIF to mediate the apoptosis response under Doxorubicin treatment.
Conclusion:
Our results provided novel insights into the downstream molecular pathways underlying Doxorubicin treatment and suggested that manipulation of Notch signaling pathway could have synergistic effect with Doxorubicin for cancer treatment.
Insights
Doxorubicin chemotherapy activates the Notch pathway, specifically HES1, which is crucial for inducing cancer cell death. Modulating this pathway may enhance Doxorubicin
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Doxorubicin is a vital chemotherapy agent with significant side effects.
- Understanding Doxorubicin's molecular targets is key to improving cancer treatment efficacy.
- The Notch signaling pathway's role in Doxorubicin's action requires elucidation.
Purpose of the Study:
- To investigate the downstream molecular pathways of Doxorubicin in cancer cells.
- To determine the role of the Notch signaling pathway in Doxorubicin-induced apoptosis.
- To explore HES1 as a potential mediator of Doxorubicin's anti-cancer effects.
Main Methods:
- HeLa S3 cells were treated with Doxorubicin.
- Notch pathway gene expression was quantified using Real-Time qRT-PCR.
- HES1 expression was manipulated via lentiviral transfection.
- Cell proliferation and apoptosis were assessed using MTT assays and flow cytometry.
- Protein localization was analyzed by immunofluorescence.
Main Results:
- Doxorubicin significantly upregulated Notch pathway components in cancer cells.
- Doxorubicin treatment activated the Notch target HES1, which is essential for apoptosis.
- Overexpression of HES1 potentiated Doxorubicin-induced apoptosis.
- HES1 mediated apoptosis by activating PARP1 and regulating AIF subcellular localization.
Conclusions:
- Doxorubicin's anti-cancer effects involve the activation of the Notch signaling pathway.
- HES1 plays a critical role in mediating Doxorubicin-induced cancer cell apoptosis.
- Targeting the Notch pathway could enhance Doxorubicin's efficacy in cancer therapy.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

